The CEO succession comes as the firm intends to conduct a comprehensive strategic review.
The firm’s new managing director joins from Epoch Investment Partners.
They will help source new transactions, perform due diligence and support portfolio company management teams.
Benchmark reveals transparency as a proxy for better outcomes.
He will implement investment strategy and oversee portfolio construction and trading.
He was most recently chairman and ceo at global contract research organization PRA Health Sciences.
He will be responsible for helping lead capital markets activities across all aspects of the investment and portfolio management processes.
They join the firm from Highmark Capital Management and Guggenheim Investments, respectively.
Tampa Bay-based companies and private equity funds have received more than $185 million worth of Florida Growth Fund investments since its inception in 2009.
The pension giant just delivered its worst performance since the Great Recession.